Raphael Pharmaceutical (RAPH) Other Working Capital Changes (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Other Working Capital Changes of -$6000.0 for Q3 2025, up 81.82% sequentially from -$33000.0 in Q2 2025, and down 300.0% YoY from $3000.0 in Q3 2024.
Raphael Pharmaceutical (RAPH) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Other Working Capital Changes for 6 years, with the latest figure at -$6000.0 in Q3 2025.
- Quarterly Other Working Capital Changes fell 300.0% year-over-year to -$6000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$7000.0 (down 216.67% YoY) and the FY2024 annual result came in at -$1000.0, up 97.22% from the prior year.
- Other Working Capital Changes improved to -$6000.0 in Q3 2025 per RAPH's latest filing, from -$33000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $244000.0 in Q4 2021 and troughed at -$170000.0 in Q1 2022.
- A 5-year average of -$11894.7 and a median of -$4000.0 in 2021 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 483.33% in 2025, down 371.43% in 2025.
- Over 5 years, Other Working Capital Changes stood at $244000.0 in 2021, then slumped by 93.03% to $17000.0 in 2022, then plunged by 76.47% to $4000.0 in 2023, then sank by 175.0% to -$3000.0 in 2024, then sank by 100.0% to -$6000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$6000.0, -$33000.0, and $35000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -33,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |